FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts. [electronic resource]
Producer: 20000316Description: 135-41 p. digitalISSN:- 0023-6837
- Arthritis, Rheumatoid -- enzymology
- Base Sequence
- Cells, Cultured
- Cyclooxygenase 2
- DNA Primers
- Dexamethasone -- pharmacology
- Down-Regulation -- drug effects
- Fibroblasts -- drug effects
- Fluorescent Antibody Technique, Indirect
- Humans
- Isoenzymes -- genetics
- Membrane Proteins
- NF-kappa B -- metabolism
- Promoter Regions, Genetic
- Prostaglandin-Endoperoxide Synthases -- genetics
- RNA, Messenger -- genetics
- Receptors, Glucocorticoid -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Subcellular Fractions -- metabolism
- Synovial Membrane -- drug effects
- Tacrolimus -- pharmacology
- Transcription, Genetic -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.